Association between LDL, Apolipoprotein-B Apolipoprotein A-I and Lipoprotein(a) and Severity of Coronary Artery Disease Based on Coronary Angiography


Atherosclerosis is the most important contributor to increasing burden of coronary artery disease (CAD). Growing evidence suggests that the ratios of Apo B/Apo A-I and Lp(a) are better indexes for risk assessment of CAD. Elevated plasma levels of lipoprotein(a) in humans represent a major in-herited risk factor for atherosclerosis. Thus, a study was performed to determine the association betwwen serum Apo B, Apo A-I, and lipoprotein(a) levels, and severity of CAD in patients with CAD confirmed on coronary angiography findings. An analytical case control study was carried out with 85 patients (58 males and 27 females) 40 - 60 years of age confirmed as having CAD on coronary angiography and 85 age and sex matched healthy volunteers as controls. Serum samples were an-alyzed for Apo A-1 LDL, Apo B, Apo A-I, and lipoprotein(a) concentration and the severity of CAD was assessed using coronary angiography scoring method. Patients with CAD had significantly high serum LDL-C, Apo B and Lp(a) levels compared to control subjects. However, serum Apo A-I level did not show a significant difference between two groups. Subjects with a positive family history of CAD with increased serum Lp(a) ≥ 17.3 mg/dL have high risk for development of CAD. Present study suggests that serum Lp(a) cut-off value of 17.3 mg/dL may be an important predictor in ruling out major vessel disease and luminal narrowing by atheroma.

Share and Cite:

Perera, P. , Wickramasinghe, D. , Peiris, H. , Chandrasena, L. and Senaratne, V. (2015) Association between LDL, Apolipoprotein-B Apolipoprotein A-I and Lipoprotein(a) and Severity of Coronary Artery Disease Based on Coronary Angiography. Journal of Biosciences and Medicines, 3, 53-61. doi: 10.4236/jbm.2015.38006.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Weinbrenner, T., Cladellas, M., Covas, MI., Fito, M., Tomas, M., Senti, M., Bruguera, J. and Marrugat, J. (2003) High Oxidative Stress in Patients with Stable Coronary Artery Disease. Atherosclerosis, 168, 99-106.
[2] Serdar, Z., Aslan, K., Dirican, M., Sarandol, E., Yesilbursa, D. and Serdar, A. (2006) Lipid and Protein Oxidation and Antioxidant Status in Patients with Angiographically Proven Coronary Artery Disease. Clinical Biochemistry, 39, 794- 803.
[3] Rasouli, M., Kiasari, A.M. and Mokhberi, V. (2006) The Ratio of apoB/apoAI, apoB and Lipoprotein(a) Are the Best Predictors of Stable Coronary Artery Disease. Clinical Chemistry and Laboratory Medicine, 44, 1015-1021.
[4] Prins, J., Leus, F.R., Bouma, B.N. and Van, H.J.M. (1996) Differentiation of the Roles of the Apolipoprotein(a) and LDL Moiety in the Binding of Lipoprotein(a) to Limited Plasmin Digested Des AA Fibrin. Fibrinolysis, 10, 317-324.
[5] Berglund, L., and Ramakrishnan, R. (2004) Lipoprotein(a): An Elusive Cardiovascular Risk Factor. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 2219-2226.
[6] Bergmark, C., Dewan, A. and Orsoni, A., Merki, E., Miller, E.R., Shin, M.J., Binder, C.J., Horkko, S., Krauss, R.M., Chapman, M.J., Witztum, J.L. and Tsimikas, S. (2008) A Novel Function of Lipoprotein [a] as a Preferential Carrier of Oxidized Phospholipids in Human Plasma. Journal of Lipid Research, 49, 2230-2239.
[7] Sullivan, D.R., Thomas, M.B., Marwicks, M.B. and Freedman, B. (1990) A New Method of Scoring Coronary Angiograms to Reflect Extent of Coronary Atherosclerosis and Improves Correlation with Major Risk Factors. American Heart Journal, 119, 1262-1266.
[8] Nauck, M., Warnick, G.R. and Rifai, N. (2002) Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation. Clinical Chemistry, 48, 236-254.
[9] Marcovina, S.M., Albers, J.J., Dati, F., Ledue, T.B. and Richitie, R.F. (1991) International Federation of Clinical Chemistry Standarization Project for Measurements of Apolipoproteins A-I and B. Clinical Chemistry, 37, 1676-1682.
[10] Reardon, M.F., Nestel, P.J., Craig, I.H. and Harper, R.W. (1985) Lipoprotein Predictors of the Severity of Coronary Artery Disease in Men and Women. Circulation, 71, 881-888.
[11] Hamsten, A., Walldius, G., Szamosi, A., Dahlen, G. and de Faire, U. (1986) Relationship of Angiographically Defined Coronary Artery Disease to Serum Lipoproteins and Apolipoproteins in Young Survivors of Myocardial Infarction. Circulation, 73, 1097-1110.
[12] Veeranna, V., Pradhan, J., Niraj, A., Fakhry, H. and Afonso, L. (2010) Traditional Cardiovascular Risk Factors and Severity of Angrographic Coronary Artery Disease in the Elderly. Preventive Cardiology, 13, 135-140.
[13] Mallika, V., Goswami, B. and Rajappa, M. (2007) New Risk Factor-Atherosclerosis Is Pathophysiology and the Role of Novel Risk Factors: A Clinicobiochemical Perspective. Angiology, 58, 513-522.
[14] Aksoy, S., Cam, N., Gurkan, U., Oz, D., Ozden, K., Altay, S., Durmus, G. and Agirbasli, M. (2012) Oxidative Stress and Severity of Coronary Artery Disease in Young Smokers with Acute Myocardial Infarction. Cardiology Journal, 19, 381-386.
[15] Sigurdsson, G., Baldursdottir, A., Sigvaldason, H., Agnarsson, U., Thorgeirsson, G. and Sigfusson, N. (1992) Predictive Value of Apolipoproteins in a Prospective Survey of Coronary Artery Disease in Men. The American Journal of Cardiology, 69, 1251-1254.
[16] Mukamal, K.J., Kronmal, R.A., Tracy, R.P., Cushman, M. and Siscovick, D.S. (2004) Traditional and Novel Risk Factors in Older Adults: Cardiovascular Risk Assessment Late in Life. The American Journal of Geriatric Cardiology, 13, 69-78.
[17] Sharreft, A.R., Ballantyne, C.M., Coady, S.A., Heiss, G., Sorlie, P.D. and Catellier, D. (2001) Atherosclorosis Risk in Communities Study Group. Coronary Heart Disease Prediction from Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoprotein A-1 and B and HDL Density Sub Fractions. The Atherosclorosis Risk in Communities (ARIC) Study. Circulation, 104, 1108-1113.
[18] Gupta, R., Vasisht, S.D., Bahl, V.K. and Wasir, H.S. (1996) Correlation of Lipoprotein(a) to Angiographically Defined Coronary Artery Disease in Indians. International Journal of Cardiology, 57, 265-270.
[19] Danesh, J., Collins, R. and Peto, R. (2000) Lipoprotein(a) and Coronary Artery Disease. Meta-Analysis of Prospective Studies. Circulation, 102, 1082-1085.
[20] Sokhanvar, S., Mazaki, R.R.S., Mousavinasab, N. and Golmohammadi, Z. (2011) The Association between Serum Lipoprotein(a) and Other Cardiac Risk Factors with the Severity of Coronary Artery Disease. Journal of Cardiovascular and Thoracic Research, 3, 35-39.
[21] Baldassare, D., Tremoli, E., Franceschini, G., Ichelagnoli, S. and Sirtori, C.R. (1996) Plasma Lipoprotein(a) Is an Independent Factor Associated with Carotid Wall Thickening in Severity but Not Moderately Hyper Cholesterolaemic Patients. Stroke, 27, 1044-1049.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.